Detection of parathyroid hormone-like hormone in cancer cell cultures by gold nanoparticle-based lateral flow immunoassays

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 12, Issue 1, 2016, Pages 53-61

  Chamorro Garcia, Alejandro ^a,b   de la Escosura Muñiz, Alfredo ^a   Espinoza Castañeda, Marisol ^a   Rodriguez Hernandez, Carlos J ^b   de Torres, Carmen ^b   Merkoçi, Arben ^a,c  

^a CATALAN INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY ICN2   (Spain)

^b HOSPITAL SANT JOAN DE DÉU   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

HaCaT; LA N 1; Lateral flow immunoassay (LFIA); Parathyroid hormone like hormone (PTHLH); SK N AS

Indexed keywords

DIAGNOSIS; DISEASES; FIBER OPTIC SENSORS; GOLD; IMMUNOLOGY; METAL NANOPARTICLES; NANOPARTICLES; TUMORS;

CULTURE MEDIA; GOLD NANOPARTICLES; HACAT; HUMAN CELL LINES; HUMAN SERUM; LATERAL FLOW IMMUNOASSAY; LATERAL FLOW IMMUNOASSAYS (LFIA); PARATHYROID HORMONES;

CELL CULTURE;

ANTIBODY CONJUGATE; GOLD NANOPARTICLE; PARATHYROID HORMONE DERIVATIVE; PARATHYROID HORMONE LIKE HORMONE; UNCLASSIFIED DRUG; GOLD; METAL NANOPARTICLE; PARATHYROID HORMONE; TUMOR MARKER;

ARTICLE; CANCER CELL CULTURE; CELL LYSATE; CHEMICAL REACTION KINETICS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; EVALUATION STUDY; HORMONE DETERMINATION; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; LATERAL FLOW IMMUNOASSAY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PH; SURFACE CHARGE; SURFACE PROPERTY; WESTERN BLOTTING; CHEMISTRY; DEVICE FAILURE ANALYSIS; DEVICES; EQUIPMENT DESIGN; IMMUNOLOGY; MICROFLUIDIC ANALYSIS; NEOPLASMS, EXPERIMENTAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TUMOR CELL LINE; ULTRASTRUCTURE;

BIOMARKERS, TUMOR; CELL LINE, TUMOR; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; GOLD; HUMANS; IMMUNOASSAY; METAL NANOPARTICLES; MICROFLUIDIC ANALYTICAL TECHNIQUES; NEOPLASMS, EXPERIMENTAL; PARATHYROID HORMONE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84957103263     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2015.09.012     Document Type: Article

References (42)

1. Moseley J.M., Kubota M., Diefenbachjagger H., Wettenhall R.E.H., Kemp B.E., Suva L.J., et al. Parathyroid hormone-related protein purified from a human-lung cancer cell-line. Proc Natl Acad Sci U S A 1987, 84:5048-5052.
2. Moseley J.M., Gillespie M.T. Parathyroid hormone-related protein. Crit Rev Clin Lab Sci 1995, 32:299-343.
3. Suva L.J., Winslow G.A., Wettenhall R.E.H., Hammonds R.G., Moseley J.M., Diefenbachjagger H., et al. A parathyroid-hormone related protein implicated in malignant hypercalcemia-cloning and expression. Science 1987, 237(80-):893-896.
4. Liao J., McCauley L.K. Skeletal metastasis: established and emerging roles of parathyroid hormone related protein (PTHrP). Cancer Metastasis Rev 2006, 25:559-571.
5. McCauley L.K., Martin T.J. Twenty-five years of PTHrP progress: from cancer hormone to multifunctional cytokine. J Bone Miner Res 2012, 27:1231-1239.
6. Soki F.N., Park S.I., McCauley L.K. The multifaceted actions of PTHrP in skeletal metastasis. Future Oncol 2012, 8:803-817.
7. Wysolmerski J.J., Stewart A.F. The physiology of parathyroid hormone-related protein: an emerging role as a developmental factor. Annu Rev Physiol 1998, 60:431-460.
8. Li J., Karaplis A.C., Huang D.C., Siegel P.M., Camirand A., Yang X.F., et al. PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target. J Clin Invest 2011, 121:4655-4669.
9. Park S.I., Lee C., Sadler W.D., Koh A.J., Jones J., Seo J.W., et al. Parathyroid hormone-related protein drives a CD11b(+)Gr1(+) cell-mediated positive feedback loop to support prostate cancer growth. Cancer Res 2013, 73:6574-6583.
10. Iguchi H., Tanaka S., Ozawa Y., Kashiwakuma T., Kimura T., Hiraga T., et al. An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis. Cancer Res 1996, 56:4040-4043.
11. Urosevic J., Garcia-Albéniz X., Planet E., Real S., Céspedes M.V., Guiu M., et al. Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH. Nat Cell Biol 2014, 16:685-694.
12. Wang Y., Lei R., Zhuang X., Zhang N., Pan H., Li G., et al. DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis. J Clin Invest 2014, 124:1646-1659.
13. Bilezikian J.P. Clinical utility of assays for parathyroid hormone-related protein. Clin Chem 1992, 38:179-181.
14. Fraser W.D., Robinson J., Lawton R., Durham B., Gallacher S.J., Boyle I.T., et al. Clinical and laboratory studies of a new immunoradiometric assay of parathyroid hormone-related protein. Clin Chem 1993, 39:414-419.
15. Pandian M.R., Morgan C.H., Carlton E., Segre G.V. Modified immunoradiometric assay of parathyroid hormone-related protein-clinical-application in the differential-diagnosis of hypercalcemia. Clin Chem 1992, 38:282-288.
16. Raison D., Coquard C., Hochane M., Steger J., Massfelder T., Moulin B., et al. Knockdown of parathyroid hormone related protein in smooth muscle cells alters renal hemodynamics but not blood pressure. Am J Physiol Renal Physiol 2013, 305:F333-F342.
17. Cafforio P., Savonarola A., Stucci S., De Matteo M., Tucci M., Brunetti A.E., et al. PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression. J Bone Miner Res 2014, 29:55-66.
18. Kir S., White J.P., Kleiner S., Kazak L., Cohen P., Baracos V.E., et al. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature 2014, 513:100-104.
19. de la Escosura-Muniz A., Merkoci A. Electrochemical detection of proteins using nanoparticles: applications to diagnostics. Expert Opin Med Diagn 2010, 4:21-37.
20. de la Escosura-Muniz A., Parolo C., Merkoci A. Immunosensing using nanoparticles. Mater Today 2010, 13:17-27.
21. Espinoza-Castaneda M., de la Escosura-Muniz A., Chamorro A., de Torres C., Merkoci A. Nanochannel array device operating through Prussian blue nanoparticles for sensitive label-free immunodetection of a cancer biomarker. Biosens Bioelectron 2015, 67:107-114.
22. Osikowicz G., Beggs M., Brookhart P., Caplan D., Ching S.F., Eck P., et al. One-step chromatographic immunoassay for qualitative determination of choriogonadotropin in urine. Clin Chem 1990, 36:1586-1586.
23. Parolo C., Merkoci A. Paper-based nanobiosensors for diagnostics. Chem Soc Rev 2013, 42:450-457.
24. Fernandez-Sanchez C., McNeil C.J., Rawson K., Nilsson O., Leung H.Y., Gnanapragasam V. One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum. J Immunol Methods 2005, 307:1-12.
25. Lie P., Liu J., Fang Z., Dun B., Zeng L. A lateral flow biosensor for detection of nucleic acids with high sensitivity and selectivity. Chem Commun 2012, 48:236-238.
26. Rivas L., De La Escosura-Muñiz A., Serrano L., Altet L., Francino O., Sanchez A., et al. Triple lines gold nanoparticle-based lateral flow for enhanced and simultaneous Leishmania DNA detection and endogenous control. Nano Res 2015, 8(11):3704-3714.
27. Anfossi L., Baggiani C., Giovannoli C., D'Arco G., Giraudi G. Lateral-flow immunoassays for mycotoxins and phycotoxins: a review. Anal Bioanal Chem 2013, 405:467-480.
28. Lopez Marzo A.M., Pons J., Blake D.A., Merkoci A. All-integrated and highly sensitive paper based device with sample treatment platform for CD2+ immunodetection in drinking/tap waters. Anal Chem 2013, 85:3532-3538.
29. de la Escosura-Muniz A., Parolo C., Maran F., Merkoci A. Size-dependent direct electrochemical detection of gold nanoparticles: application in magnetoimmunoassays. Nanoscale 2011, 3:3350-3356.
30. Nunes Pauli G.E., de la Escosura-Muniz A., Parolo C., Helmuth Bechtold I., Merkoci A. Lab-in-a-syringe using gold nanoparticles for rapid immunosensing of protein biomarkers. Lab Chip 2015, 15:399-405.
31. Parolo C., de la Escosura-Muñiz A., Merkoçi A. Enhanced lateral flow immunoassay using gold nanoparticles loaded with enzymes. Biosens Bioelectron 2013, 40:412-416.
32. Parolo C., Medina-Sanchez M., de la Escosura-Muniz A., Merkoci A. Simple paper architecture modifications lead to enhanced sensitivity in nanoparticle based lateral flow immunoassays. Lab Chip 2013, 13:386-390.
33. Rivas L., Medina-Sánchez M., De La Escosura-Muñiz A., Merkoçi A. Improving sensitivity of gold nanoparticle-based lateral flow assays by using wax-printed pillars as delay barriers of microfluidics. Lab Chip 2014, 14:4406-4414.
34. de Torres C., Beleta H., Diaz R., Toran N., Rodriguez E., Lavarino C., et al. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors. Cancer 2009, 115:2792-2803.
35. Turkevich J., Stevenson P.C., Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 1951, 11:55-75.
36. Ambrosi A., Castañeda M.T., Killard A.J., Smyth M.R., Alegret S., Merkoçi A. Double-codified gold nanolabels for enhanced immunoanalysis. Anal Chem 2007, 79:5232-5240.
37. Bradford M.M. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
38. Ferguson R.E., Carroll H.P., Harris A., Maher E.R., Selby P.J., Banks R.E. Housekeeping proteins: a preliminary study illustrating some limitations as useful references in protein expression studies. Proteomics 2005, 5:566-571.
39. Am Chem Soc Comm Environ, I Guidelines for data acquisition and data quality evaluation in environmental chemistry. Anal Chem 1980, 52:2242-2257.
40. Armbruster D.A., Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 2008, 29(Suppl. 1):S49-S52.
41. Heath J.K., Southby J., Fukumoto S., Okeeffe L.M., Martin T.J., Gillespie M.T. Epidermal growth factor-stimulated parathyroid hormone-related protein expression involves increased gene-transcription and messenger-RNA stability. Biochem J 1995, 307:159-167.
42. Ellison S.L.R., Thompson M. Standard additions: myth and reality. Analyst 2008, 133:992-997.